Literature DB >> 11879137

Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.

Kathleen S Kunert1, Ann S Tisdale, Ilene K Gipson.   

Abstract

OBJECTIVES: To compare conjunctival goblet cell numbers as well as epithelial turnover in patients with non-Sjögren syndrome--associated keratoconjunctivitis sicca (NSS-KCS) and those with SS-KCS before and after 6 months of treatment with topical cyclosporine A (CsA) ophthalmic emulsion.
METHODS: Conjunctival biopsy specimens from 16 patients with NSS-KCS and 12 with SS-KCS were obtained at baseline and after 6 months' therapy with CsA or vehicle alone. Conjunctival biopsy specimens were also obtained from 11 normal subjects. Periodic acid--Schiff staining determined the number of goblet cells present. Immunofluorescence microscopy for Ki-67 localization was used to evaluate the number of actively cycling cells.
RESULTS: Periodic acid--Schiff staining showed fewer goblet cells at baseline in both dry eye populations when compared with normal subjects (P<.001). After 6 months of CsA treatment, conjunctival biopsy specimens of both NSS-KCS and SS-KCS groups revealed an increase in goblet cells compared with baseline (P<.05). More Ki-67--positive cells were observed in NSS-KCS conjunctiva at baseline than in normal conjunctiva (P<.05) whereas numbers of these cells in SS-KCS conjunctiva were similar to normal at baseline. After 6 months of CsA treatment, conjunctival biopsy specimens of NSS-KCS revealed a decrease in Ki-67--labeled cells compared with baseline (P<.001). In contrast, no substantial change was observed for CsA treatment in patients with SS-KCS.
CONCLUSIONS: Treatment of dry eye syndrome for 6 months with topical CsA resulted in an increase in goblet cell numbers in patients with NSS-KCS and SS-KCS and a decrease in epithelial turnover in those with NSS-KCS. Reducing ocular surface inflammation might have an effect on the proliferative activity of the epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879137     DOI: 10.1001/archopht.120.3.330

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  95 in total

1.  The treatment of dry eyes.

Authors:  J P Whitcher
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 2.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

3.  Current practice pattern for dry eye patients in South Korea: a multicenter study.

Authors:  Jong Suk Song; Joon Young Hyon; Doh Lee; Euisang Chung; Chulyoung Choi; Jeongbok Lee; Hyo Myung Kim
Journal:  Korean J Ophthalmol       Date:  2014-03-14

4.  Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease.

Authors:  Consuelo Pérez-Rico; Francisco Germain; María Castro-Rebollo; Agustín Moreno-Salgueiro; Miguel Ángel Teus
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

Review 5.  [The dry eye. Current concepts on classification, diagnostics, and pathogenesis].

Authors:  C Jacobi; T Dietrich; C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

6.  Neurologic evaluation of acute lacrimomimetic effect of cyclosporine in an experimental rabbit dry eye model.

Authors:  Hiroshi Toshida; Doan H Nguyen; Roger W Beuerman; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-14       Impact factor: 4.799

7.  Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.

Authors:  Rodrigo Guimaraes de Souza; Zhiyuan Yu; Michael E Stern; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  J Ocul Pharmacol Ther       Date:  2018-06-29       Impact factor: 2.671

8.  Corneal epithelial proliferation and thickness in a mouse model of dry eye.

Authors:  Claudia Fabiani; Stefano Barabino; Saadia Rashid; M Reza Dana
Journal:  Exp Eye Res       Date:  2009-03-17       Impact factor: 3.467

9.  Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.

Authors:  Ugur Keklikci; Sevda I Soker; Yildirim B Sakalar; Kaan Unlu; Selver Ozekinci; Selcuk Tunik
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

10.  Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss.

Authors:  Stephen C Pflugfelder; Cintia S De Paiva; Quianta L Moore; Eugene A Volpe; De-Quan Li; Koray Gumus; Mahira L Zaheer; Rosa M Corrales
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.